| Item Type | Name |
|
Academic Article
|
Prevalence of depressive symptoms among white and African-American caregivers of demented patients.
|
|
Academic Article
|
Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation.
|
|
Academic Article
|
Identifying persons with dementia by use of a caregiver telephone interview.
|
|
Academic Article
|
Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis.
|
|
Academic Article
|
Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.
|
|
Academic Article
|
The search for better noncholinergic treatment options for Alzheimer's disease.
|
|
Academic Article
|
Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease.
|
|
Academic Article
|
Psychosis in elderly patients: classification and pharmacotherapy.
|
|
Academic Article
|
What are the challenges faced by psychiatrists in the management of Alzheimer's disease?
|
|
Academic Article
|
Alzheimer's Disease in the Family Practice Setting: Assessment of a Screening Tool.
|
|
Academic Article
|
The growing, ethnically diverse aging population: is our field advancing with it?
|
|
Academic Article
|
Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.
|
|
Academic Article
|
Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial.
|
|
Academic Article
|
Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.
|
|
Academic Article
|
Introduction: the clinical impact of agitation in various psychiatric disorders: management consensus and controversies.
|
|
Academic Article
|
The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
|
|
Academic Article
|
Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.
|
|
Academic Article
|
Sertraline for the treatment of depression in Alzheimer disease.
|
|
Academic Article
|
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ? 2 (DIADS-2)?
|
|
Academic Article
|
The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design.
|
|
Academic Article
|
Caregiving for Hispanic Alzheimer's disease patients: understanding the problem.
|
|
Academic Article
|
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.
|
|
Academic Article
|
The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure.
|
|
Academic Article
|
Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET).
|
|
Academic Article
|
Efficacy and adverse effects of clozapine in four elderly psychotic patients.
|
|
Academic Article
|
Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach.
|
|
Academic Article
|
Fluoroquinolone inhibition of clozapine metabolism.
|
|
Academic Article
|
A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.
|
|
Academic Article
|
Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'.
|
|
Academic Article
|
Design of Depression in Alzheimer's Disease Study-2.
|
|
Academic Article
|
The many faces of psychosis in the elderly.
|
|
Academic Article
|
Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
|
|
Academic Article
|
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
|
|
Academic Article
|
Sertraline for the treatment of depression in Alzheimer disease: genetic influences.
|
|
Academic Article
|
Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.
|
|
Academic Article
|
SIADH associated with fluoxetine and sertraline therapy.
|
|
Academic Article
|
Zolpidem for the treatment of agitation in elderly demented patients.
|
|
Concept
|
Geriatric Psychiatry
|
|
Concept
|
Diagnosis, Dual (Psychiatry)
|
|
Academic Article
|
Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2.
|
|
Academic Article
|
Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.
|
|
Academic Article
|
Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.
|
|
Academic Article
|
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial.
|
|
Academic Article
|
Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.
|
|
Academic Article
|
Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations.
|
|
Academic Article
|
A retrospective, population-based cohort study of driving under the influence, Alzheimer's disease diagnosis, and survival.
|
|
Academic Article
|
Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.
|
|
Academic Article
|
Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments.
|